FOLD Market Cap History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Also see: FOLD Shares Outstanding History and FOLD YTD Return |
FOLD Market Cap History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Also see: FOLD Shares Outstanding History and FOLD YTD Return |
FOLD Market Cap History Chart | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
+32.38% CAGR Mouse over chart for data details
|
FOLD Stock Price Chart |
About Amicus Therapeutics Inc |
Amicus Therapeutics is a biotechnology company focused on discovering, developing, and delivering medicines for diseases. Co.'s gene therapy portfolio pipeline include Pompe disease, Fabry disease, CDKL5 deficiency disorder, ceroid lipofuscinosis, neuronal, Mucopolysaccharidosis Type IIIB, as well as a program in Mucopolysaccharidosis Type IIIA. Co.'s collaboration with University of Pennsylvania also provides Co. with disease-specific access and option rights to develop new gene therapy platform technologies and programs for most lysosomal disorders and a portfolio of other rare diseases. We show 56 historical shares outstanding datapoints in our FOLD shares outstanding history coverage, used to compute FOLD market cap on those dates. Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing FOLD market cap history over the course of time is important for investors interested in comparing FOLD's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of FOLD versus a peer is one thing; comparing FOLD market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like FOLD can fluctuate over the course of history. With this page we aim to empower investors researching FOLD by allowing them to research the FOLD market cap history. |
FOLD Current Stock Quote |
Free FOLD Email Alerts: Get Dividend Alerts Get SEC Filing Alerts |
Video: The Importance of Market Cap | |
|
FOLD Share Performance |
Market Cap Peers |
Amicus Therapeutics (FOLD) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:
FONR Market Cap History |
Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 9.5%—Every Month—Forever.
You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 9.5%.